Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

CREG1 promotes uncoupling protein 1 expression and brown adipogenesis in vitro.

Kusudo T, Hashimoto M, Kataoka N, Li Y, Nozaki A, Yamashita H.

J Biochem. 2018 Oct 6. doi: 10.1093/jb/mvy083. [Epub ahead of print]

PMID:
30295852
2.

Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of β- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy.

Horie I, Haraguchi A, Sako A, Akeshima J, Niri T, Shigeno R, Ito A, Nozaki A, Natsuda S, Akazawa S, Mori Y, Ando T, Kawakami A, Abiru N.

Diabetes Res Clin Pract. 2018 Oct;144:161-170. doi: 10.1016/j.diabres.2018.08.015. Epub 2018 Sep 6.

PMID:
30194951
3.

Ultrashort time-to-echo quantitative magnetic resonance imaging of the triangular fibrocartilage: differences in position.

Fujisaki A, Aoki T, Narimatsu H, Kuwahara C, Nozaki A, Menuki K, Sakai A, Korogi Y.

Eur Radiol. 2018 Sep 3. doi: 10.1007/s00330-018-5693-7. [Epub ahead of print]

PMID:
30178144
4.

Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment.

Fukuda H, Numata K, Hara K, Nozaki A, Kondo M, Chuma M, Nakano M, Nozawa A, Maeda S, Tanaka K.

J Cancer. 2018 Jun 14;9(13):2408-2414. doi: 10.7150/jca.24236. eCollection 2018.

5.

Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.

Funakoshi T, Horimatsu T, Nakamura M, Shiroshita K, Suyama K, Mukoyama M, Mizukami T, Sakurada T, Baba E, Tsuruya K, Nozaki A, Yahata K, Ozaki Y, Ubara Y, Yasui H, Yoshimoto A, Fukuma S, Kondo N, Matsubara T, Matsubara K, Fukuhara S, Yanagita M, Muto M.

ESMO Open. 2018 Feb 23;3(2):e000301. doi: 10.1136/esmoopen-2017-000301. eCollection 2018.

6.

Sex differences in insulin and glucagon responses for glucose homeostasis in young healthy Japanese adults.

Horie I, Abiru N, Eto M, Sako A, Akeshima J, Nakao T, Nakashima Y, Niri T, Ito A, Nozaki A, Haraguchi A, Akazawa S, Mori Y, Ando T, Kawakami A.

J Diabetes Investig. 2018 Nov;9(6):1283-1287. doi: 10.1111/jdi.12829. Epub 2018 Mar 30.

7.

Relation between change in treatment for central diabetes insipidus and body weight loss.

Ito A, Nozaki A, Horie I, Ando T, Kawakami A.

Minerva Endocrinol. 2018 Feb 8. doi: 10.23736/S0391-1977.18.02718-9. [Epub ahead of print]

PMID:
29424204
8.

Quantitative estimation of progression of chronic liver disease using gadoxetate disodium-enhanced magnetic resonance imaging.

Yamada A, Fujinaga Y, Suzuki T, Komatsu D, Kitoh Y, Iwadate Y, Nozaki A, Ueda K, Kadoya M.

Hepatol Res. 2018 Aug;48(9):735-745. doi: 10.1111/hepr.13069. Epub 2018 Mar 9.

PMID:
29396898
9.

First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.

Makiyama A, Kunieda K, Noguchi M, Kajiwara T, Tamura T, Takeda K, Sugiyama J, Minashi K, Moriwaki T, Sugimoto N, Nagase M, Negoro Y, Tsuda T, Shimodaira H, Okano N, Tsuji A, Sakai D, Yanagihara K, Ueda S, Tamura S, Otsu S, Honda T, Matsushita Y, Okuno T, Kashiwada T, Nozaki A, Ebi M, Okuda H, Shimokawa M, Hironaka S, Hyodo I, Baba E, Boku N, Muro K, Esaki T.

Gastric Cancer. 2018 Sep;21(5):792-801. doi: 10.1007/s10120-018-0797-y. Epub 2018 Jan 20.

PMID:
29353332
10.

Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study.

Uneno Y, Taneishi K, Kanai M, Okamoto K, Yamamoto Y, Yoshioka A, Hiramoto S, Nozaki A, Nishikawa Y, Yamaguchi D, Tomono T, Nakatsui M, Baba M, Morita T, Matsumoto S, Kuroda T, Okuno Y, Muto M.

PLoS One. 2017 Aug 24;12(8):e0183291. doi: 10.1371/journal.pone.0183291. eCollection 2017.

11.

Silent navigator-triggered silent MRI of the abdomen.

Iwadate Y, Nozaki A, Nunokawa Y, Okuda S, Jinzaki M, Kabasawa H.

Magn Reson Med. 2018 Apr;79(4):2170-2175. doi: 10.1002/mrm.26869. Epub 2017 Aug 7.

PMID:
28782173
12.

Transvenous Intravascular Ultrasound-Guided Endovascular Treatment for Chronic Total Occlusion of the Infrainguinal Arteries.

Takahashi Y, Sato T, Okazaki H, Nozaki A, Matsushita M, Kamiya M, Shimizu W.

J Endovasc Ther. 2017 Oct;24(5):718-726. doi: 10.1177/1526602817723139. Epub 2017 Aug 2.

PMID:
28766400
13.

A new device for fiducial registration of image-guided navigation system for liver RFA.

Doba N, Fukuda H, Numata K, Hao Y, Hara K, Nozaki A, Kondo M, Chuma M, Tanaka K, Takebayashi S, Koizumi N, Kobayashi A, Tokuda J, Maeda S.

Int J Comput Assist Radiol Surg. 2018 Jan;13(1):115-124. doi: 10.1007/s11548-017-1647-9. Epub 2017 Jul 17.

PMID:
28718001
14.

Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression.

Kondo M, Numata K, Hara K, Nozaki A, Fukuda H, Chuma M, Maeda S, Tanaka K.

Gastroenterol Res Pract. 2017;2017:5728946. doi: 10.1155/2017/5728946. Epub 2017 Jun 22.

15.

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.

Ito T, Honma Y, Hijioka S, Kudo A, Fukutomi A, Nozaki A, Kimura Y, Motoi F, Isayama H, Komoto I, Hisamatsu S, Nakajima A, Shimatsu A.

Invest New Drugs. 2017 Aug;35(4):499-508. doi: 10.1007/s10637-017-0466-8. Epub 2017 May 3.

16.

Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients.

Tarao K, Tanaka K, Nozaki A, Sato A, Ishii T, Komatsu H, Ikeda T, Komatsu T, Matsushima S, Oshige K.

World J Hepatol. 2017 Apr 18;9(11):544-550. doi: 10.4254/wjh.v9.i11.544.

17.

Dynamic visual responses of accommodation and vergence to electro-holographic images.

Nozaki A, Mitobe M, Okuyama F, Sakamoto Y.

Opt Express. 2017 Feb 20;25(4):4542-4551. doi: 10.1364/OE.25.004542.

PMID:
28241657
18.

Utility of real-time prospective motion correction (PROMO) for segmentation of cerebral cortex on 3D T1-weighted imaging: Voxel-based morphometry analysis for uncooperative patients.

Igata N, Kakeda S, Watanabe K, Nozaki A, Rettmann D, Narimatsu H, Ide S, Abe O, Korogi Y.

Eur Radiol. 2017 Aug;27(8):3554-3562. doi: 10.1007/s00330-016-4730-7. Epub 2017 Jan 23.

PMID:
28116516
19.

The prognostic impact of gender in patients with acute heart failure - An evaluation of the age of female patients with severely decompensated acute heart failure.

Nozaki A, Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Nishigoori S, Uchiyama S, Kusama Y, Asai K, Shimizu W.

J Cardiol. 2017 Sep;70(3):255-262. doi: 10.1016/j.jjcc.2016.11.015. Epub 2016 Dec 29.

20.

Utility of real-time prospective motion correction (PROMO) on 3D T1-weighted imaging in automated brain structure measurements.

Watanabe K, Kakeda S, Igata N, Watanabe R, Narimatsu H, Nozaki A, Dan Rettmann, Abe O, Korogi Y.

Sci Rep. 2016 Dec 5;6:38366. doi: 10.1038/srep38366.

21.

A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.

Matsumoto R, Numata K, Doba N, Hara K, Chuma M, Fukuda H, Nozaki A, Tanaka K, Ishii Y, Maeda S.

J Med Ultrason (2001). 2016 Oct;43(4):545-51. doi: 10.1007/s10396-016-0740-y. Epub 2016 Aug 30.

PMID:
27577564
22.

Interaction properties of human TRAMP-like proteins and their role in pre-rRNA 5'ETS turnover.

Sudo H, Nozaki A, Uno H, Ishida Y, Nagahama M.

FEBS Lett. 2016 Sep;590(17):2963-72. doi: 10.1002/1873-3468.12314. Epub 2016 Aug 6.

23.

A retrospective analysis of patient-specific factors on voriconazole clearance.

Dote S, Sawai M, Nozaki A, Naruhashi K, Kobayashi Y, Nakanishi H.

J Pharm Health Care Sci. 2016 Apr 19;2:10. doi: 10.1186/s40780-016-0044-9. eCollection 2016.

24.

[Hepatitis B virus management to prevent reactivation].

Nozaki A, Chuma M.

Nihon Rinsho. 2015 Dec;73 Suppl 9:443-7. Japanese. No abstract available.

PMID:
26845975
25.

Skeletal Ni Catalysts Prepared from Amorphous Ni-Zr Alloys: Enhanced Catalytic Performance for Hydrogen Generation from Ammonia Borane.

Nozaki A, Tanihara Y, Kuwahara Y, Ohmichi T, Mori K, Nagase T, Yasuda HY, Yamashita H.

Chemphyschem. 2016 Feb 3;17(3):412-7. doi: 10.1002/cphc.201500964. Epub 2015 Dec 18.

PMID:
26663589
26.

C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Otsuka R, Harada N, Aoki S, Shirai K, Nishitsuji K, Nozaki A, Hatakeyama A, Shono M, Mizusawa N, Yoshimoto K, Nakaya Y, Kitahata H, Sakaue H.

Cell Stress Chaperones. 2016 Jan;21(1):29-40. doi: 10.1007/s12192-015-0633-9. Epub 2015 Aug 30.

27.

Immunohistochemical analysis of extramammary Paget's disease with Bowenoid features: case report and review of the literature.

Kikuchi K, Moriuchi R, Inokuma D, Ito T, Kawashima K, Yoshida T, Nozaki A, Horiuchi K, Nakayama C, Itami H, Yanai M, Fukasawa Y, Kimura T, Shimizu S.

J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1404-5. doi: 10.1111/jdv.13251. Epub 2015 Aug 20. Review. No abstract available.

PMID:
26289934
28.

Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.

Numata K, Fukuda H, Nihonmatsu H, Kondo M, Nozaki A, Chuma M, Morimoto M, Oshima T, Okada M, Murakami T, Takebayashi S, Maeda S, Inayama Y, Nakano M, Tanaka K.

Abdom Imaging. 2015 Oct;40(7):2372-83. doi: 10.1007/s00261-015-0489-6.

PMID:
26099473
29.

Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire.

Nozaki A, Ando T, Akazawa S, Satoh T, Sagara I, Horie I, Imaizumi M, Usa T, Yanagisawa RT, Kawakami A.

Endocrine. 2016 Jan;51(1):140-7. doi: 10.1007/s12020-015-0637-3. Epub 2015 May 30.

PMID:
26024973
30.

Three-dimensional cardiac cine imaging using the kat ARC acceleration: Initial experience in clinical adult patients at 3T.

Okuda S, Yamada Y, Tanimoto A, Fujita J, Sano M, Fukuda K, Kuribayashi S, Jinzaki M, Nozaki A, Lai P.

Magn Reson Imaging. 2015 Sep;33(7):911-7. doi: 10.1016/j.mri.2015.04.004. Epub 2015 Apr 30.

PMID:
25936683
31.

Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.

Kamiya M, Sato N, Nozaki A, Akiya M, Okazaki H, Takahashi Y, Mizuno K, Shimizu W.

J Cardiovasc Pharmacol. 2015 Mar;65(3):282-8. doi: 10.1097/FJC.0000000000000193.

PMID:
25748698
32.

Sensitive detection of a tumor marker, α-fetoprotein, with a sandwich assay on a plasmonic chip.

Tawa K, Kondo F, Sasakawa C, Nagae K, Nakamura Y, Nozaki A, Kaya T.

Anal Chem. 2015 Apr 7;87(7):3871-6. doi: 10.1021/ac504642j. Epub 2015 Mar 10.

PMID:
25719730
33.

[Present status of regional collaboration of home care medicine at Kohka Medical County(Kohka-City and Konan-City), Shiga prefecture].

Okino T, Nozaki A, Kimura K, Kokura M, Tanaka N, Imamura Y, Azuma S, Sasaki T, Masuda K, Nakamori K, Inoshita E.

Gan To Kagaku Ryoho. 2014 Dec;41 Suppl 1:9-11. Japanese.

PMID:
25595068
34.

Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.

Irie K, Morimoto M, Numata K, Kondo M, Moriya S, Shimoyama Y, Nozaki A, Goda Y, Kobayashi S, Ueno M, Ohkawa S, Tanaka K, Maeda S.

Abdom Imaging. 2015 Aug;40(6):1821-8. doi: 10.1007/s00261-014-0332-5.

PMID:
25526685
35.

Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting.

Kondo M, Morimoto M, Ishii T, Nozaki A, Fukuda H, Numata K, Kobayashi S, Ohkawa S, Hidaka H, Nakazawa T, Shibuya A, Okuse C, Suzuki M, Sakamaki K, Morita S, Maeda S, Tanaka K.

J Dig Dis. 2015 Mar;16(3):143-51. doi: 10.1111/1751-2980.12221.

PMID:
25495751
36.

[Examination of a relapsing pattern of cases of completely resected non-small cell lung cancer].

Kambayashi T, Tottori H, Hasegawa I, Nakatsukasa H, Tsushima H, Nozaki A.

Gan To Kagaku Ryoho. 2014 Aug;41(8):971-4. Japanese.

PMID:
25132028
37.

Deoxycorticosterone-producing adenoma concomitant with aldosterone-producing microadenoma: a challenging combination.

Oyama K, Nozaki A, Horie I, Shigematsu K, Takehara K, Ando T, Kawakami A.

Endocr Pract. 2014 Sep;20(9):e171-5. doi: 10.4158/EP14175.CR.

PMID:
25100384
38.

Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer.

Yamada T, Oshima T, Yoshihara K, Sato T, Nozaki A, Shiozawa M, Ota M, Yoshikawa T, Akaike M, Numata K, Rino Y, Kunisaki C, Tanaka K, Imada T, Masuda M.

J Surg Oncol. 2014 Jun;109(8):836-40. doi: 10.1002/jso.23602. Epub 2014 Apr 2.

PMID:
24700475
39.

Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.

Fukuda H, Numata K, Moriya S, Shimoyama Y, Ishii T, Nozaki A, Kondo M, Morimoto M, Maeda S, Sakamaki K, Morita S, Tanaka K.

Radiology. 2014 Aug;272(2):598-604. doi: 10.1148/radiol.14131640. Epub 2014 Apr 2.

PMID:
24689883
40.

Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.

Numata K, Fukuda H, Miwa H, Ishii T, Moriya S, Kondo M, Nozaki A, Morimoto M, Okada M, Takebayashi S, Maeda S, Nozawa A, Nakano M, Tanaka K.

Eur J Radiol. 2014 Jan;83(1):95-102. doi: 10.1016/j.ejrad.2013.09.025. Epub 2013 Oct 6.

PMID:
24176532
41.

Drug-induced liver injury after allogeneic bone marrow transplantation.

Tachibana T, Nozaki A, Enaka M, Yamamoto E, Kawasaki R, Koharazawa H, Hagihara M, Ishibashi D, Nakajima Y, Kuwabara H, Tomita N, Ishigatsubo Y, Fujisawa S.

Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15.

PMID:
24037455
42.

Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.

Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K.

Eur J Radiol. 2013 Sep;82(9):1471-80. doi: 10.1016/j.ejrad.2013.04.045. Epub 2013 Jun 13.

PMID:
23769188
43.

High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas.

Fukuda H, Numata K, Nozaki A, Kondo M, Morimoto M, Maeda S, Tanaka K, Ohto M, Ito R, Ishibashi Y, Oshima N, Ito A, Zhu H, Wang ZB.

Abdom Imaging. 2013 Dec;38(6):1263-8. doi: 10.1007/s00261-013-0010-z.

44.

Active skeletal Ni catalysts prepared from an amorphous Ni-Zr alloy in the pre-crystallization state.

Nozaki A, Kamegawa T, Ohmichi T, Yamashita H.

Chemphyschem. 2013 Aug 5;14(11):2534-8. doi: 10.1002/cphc.201300260. Epub 2013 May 29.

PMID:
23720204
45.

Hepatic failure in pregnancy successfully treated by online hemodiafiltration: Chronic hepatitis B virus infection without viral genome mutation.

Arata S, Nozaki A, Takizawa K, Kondo M, Morimoto M, Numata K, Hayashi S, Watanabe T, Tanaka Y, Tanaka K.

Hepatol Res. 2013 Dec;43(12):1356-1360. doi: 10.1111/hepr.12090. Epub 2013 May 15.

PMID:
23675979
46.

Predictive score for survival after percutaneous cardiopulmonary support in cardiovascular disease patients- evaluation of pre-procedural information.

Shirakabe A, Nozaki A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, Matsushita M, Okazaki H, Yamamoto Y, Yokoyama S, Asai K, Mizuno K.

Circ J. 2013;77(8):2064-72. Epub 2013 Apr 25.

47.

Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.

Moriya S, Morimoto M, Numata K, Nozaki A, Shimoyama Y, Kondo M, Nakano M, Maeda S, Tanaka K.

Anticancer Res. 2013 Mar;33(3):997-1001.

PMID:
23482772
48.

Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14).

Inoue HK, Seto K, Nozaki A, Torikai K, Suzuki Y, Saitoh J, Noda SE, Nakano T.

J Radiat Res. 2013 Jul 1;54(4):727-35. doi: 10.1093/jrr/rrt006. Epub 2013 Feb 11.

49.

Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C.

Shimoyama Y, Nozaki A, Morimoto M, Moriya S, Kondo M, Fukuda H, Numata K, Miyajima E, Oba MS, Taguri M, Morita S, Maeda S, Tanaka K.

Hepatol Res. 2013 Sep;43(9):919-24. doi: 10.1111/hepr.12037. Epub 2013 Jan 2.

PMID:
23281610
50.

[Examination and care for cancer patients with difficult-to-assess pain - feed back on patients who received consultation from our palliative care team].

Kambayashi T, Tominaga A, Nakatsukasa H, Nozaki A, Toyama T.

Gan To Kagaku Ryoho. 2012 Dec;39(13):2577-9. Japanese.

PMID:
23235184

Supplemental Content

Loading ...
Support Center